COVID -19

Nasal COVID-19 Vaccine Secures Federal Funding for Groundbreaking Clinical Trial

CyanVac LLC is set to begin a federally funded Phase 2b trial this fall for its intranasal COVID-19 vaccine, CVXGA,…

20 hours ago

Dr. Brian Nadler expected to be acquitted of murder, criminal negligence charges

Dr. Brian Nadler, who formerly practised at a hospital in Hawkesbury, Ont., and is facing eight charges in connection to…

3 days ago

Head of National Microbiology Lab resigns in wake of scientist security scandal

The head of the National Microbiology Lab (NML) in Winnipeg says he is stepping down to continue his medical work and…

5 days ago

Cannabis Use Nearly Doubles Risk Of Severe COVID Infection, Hospitalization: Study

Researchers have discovered that cannabis use doubles the risk of developing severe COVID infections and hospitalizations.Previous studies have identified that…

1 week ago

Oilers, Panthers could join short list of teams to win from fall to summer in same NHL season

It's officially summer, and the best two teams in hockey during the winter months of the 2023-24 NHL season are…

2 weeks ago

Alberta government dissolves controversial energy ‘war room’

The Alberta government is shutting down the Canadian Energy Centre — the controversial energy "war room"  — and shuffling its duties into…

3 weeks ago

Canada’s Adam Hadwin tied for 2nd place headed into final round at Memorial

Scottie Scheffler hit out of a bunker over the green and into the water. He hit a tee shot over…

3 weeks ago

COVID-19 Triggers Lethal Lung Disease in Previously Unaffected Populations

A University of Leeds study found a sharp increase in a rare autoimmune disease during the COVID-19 pandemic, primarily impacting…

3 weeks ago

4 years later, COVID remains a year-round threat. Here’s why this virus isn’t seasonal quite yet

This story is part of CBC Health's Second Opinion, a weekly analysis of health and medical science news emailed to subscribers…

3 weeks ago

Scientists Race To Perfect New Oral COVID-19 Treatment Poised To Replace Paxlovid

Researchers at Rutgers University are developing a new oral COVID-19 treatment, Jun12682, which has shown potential in animal studies to…

4 weeks ago

This website uses cookies.